TrialAnnals of the rheumatic diseases2018

Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.

Merel J l'Ami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.